PPBT
Purple Biotech Ltd
A clinical-stage biotechnology company in Rehovot, Israel, developing cancer therapies that aim to overcome tumor immune evasion and drug resistance, with experimental drugs like NT219 and CM24. It began life as Kitov Pharma, which won FDA approval for Consensi, a pill combining a blood-pressure drug and an arthritis painkiller. In 2020 the company renamed itself Purple Biotech to mark its shift from that pain-and-hypertension drug to oncology.
ADRUnderlying: PPBTCUSIP: 74638P109HealthcareIL1 holder
American Depositary Shares (ADSs)